NO905411D0 - Nye 2-substituerte 4-(3-alkyl-5-tert.-4-hydroksyfenyl)-tiazoler, fremgangsmaate for deres fremstilling samt anvendelse av forbindelsene. - Google Patents

Nye 2-substituerte 4-(3-alkyl-5-tert.-4-hydroksyfenyl)-tiazoler, fremgangsmaate for deres fremstilling samt anvendelse av forbindelsene.

Info

Publication number
NO905411D0
NO905411D0 NO905411A NO905411A NO905411D0 NO 905411 D0 NO905411 D0 NO 905411D0 NO 905411 A NO905411 A NO 905411A NO 905411 A NO905411 A NO 905411A NO 905411 D0 NO905411 D0 NO 905411D0
Authority
NO
Norway
Prior art keywords
formula
radical
alkyl
group
hydrogen atom
Prior art date
Application number
NO905411A
Other languages
English (en)
Other versions
NO905411L (no
Inventor
Werner Thorwart
Rudolf Schleuerbach
Robert Bartlett
Klaus Ulrich Weithmann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO905411D0 publication Critical patent/NO905411D0/no
Publication of NO905411L publication Critical patent/NO905411L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Lubricants (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90905411A 1989-12-15 1990-12-14 Nye 2-substituerte 4-(3-alkyl-5-tert.-4-hydroksyfenyl)-tiazoler, fremgangsmaate for deres fremstilling samt anvendelse av forbindelsene. NO905411L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3941438A DE3941438A1 (de) 1989-12-15 1989-12-15 Neue 2-substituierte 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung

Publications (2)

Publication Number Publication Date
NO905411D0 true NO905411D0 (no) 1990-12-14
NO905411L NO905411L (no) 1991-06-17

Family

ID=6395527

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90905411A NO905411L (no) 1989-12-15 1990-12-14 Nye 2-substituerte 4-(3-alkyl-5-tert.-4-hydroksyfenyl)-tiazoler, fremgangsmaate for deres fremstilling samt anvendelse av forbindelsene.

Country Status (17)

Country Link
US (1) US5137897A (no)
EP (1) EP0432740B1 (no)
JP (1) JPH0517459A (no)
KR (1) KR910011813A (no)
AT (1) ATE119527T1 (no)
AU (1) AU630261B2 (no)
CA (1) CA2032282A1 (no)
DE (1) DE3941438A1 (no)
FI (1) FI906141A (no)
HU (1) HU209584B (no)
IE (1) IE904515A1 (no)
IL (1) IL96659A0 (no)
NO (1) NO905411L (no)
NZ (1) NZ236453A (no)
PT (1) PT96181A (no)
RU (2) RU2017739C1 (no)
ZA (1) ZA9010067B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2600644B2 (ja) * 1991-08-16 1997-04-16 藤沢薬品工業株式会社 チアゾリルベンゾフラン誘導体
TW211005B (no) * 1991-12-18 1993-08-11 Ciba Geigy Ag
EP0548017A1 (de) * 1991-12-18 1993-06-23 Ciba-Geigy Ag Neue Thiazole
DE19502209A1 (de) 1995-01-25 1996-08-01 Hoechst Ag Phosphonoessigsäure-Derivate und deren Verwendung zur Behandlung von degenerativen Gelenkserkrankungen
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
FR2812546B1 (fr) * 2000-08-01 2008-11-21 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
FR2799461B1 (fr) * 1999-10-11 2002-01-04 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
TWI292316B (en) * 1999-10-11 2008-01-11 Sod Conseils Rech Applic Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
WO2002094798A1 (fr) * 2001-05-23 2002-11-28 Nippon Soda Co.,Ltd. Preparation de composes thiazole
EP1787986A4 (en) * 2004-08-10 2007-08-22 Shizuoka Coffein Co Ltd HYDROXAMINE ACID DERIVATIVE AND MEDICAMENT THEREFORE AS AN ACTIVE COMPONENT
EP1939181A1 (en) 2006-12-27 2008-07-02 sanofi-aventis Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
CN114516824A (zh) * 2022-03-18 2022-05-20 广州佳途科技股份有限公司 一种硫代酰胺羧酸酯及其合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (no) * 1965-10-07
US4636516A (en) * 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds
US4535165A (en) * 1981-11-23 1985-08-13 Riker Laboratories, Inc. Substituted diazoles and thiazoles
JPS62132871A (ja) * 1985-12-03 1987-06-16 Yamanouchi Pharmaceut Co Ltd 新規チアゾ−ル誘導体
DE3702758A1 (de) * 1987-01-30 1988-09-29 Hoechst Ag Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative

Also Published As

Publication number Publication date
PT96181A (pt) 1991-09-30
DE3941438A1 (de) 1991-06-20
IE904515A1 (en) 1991-06-19
EP0432740A2 (de) 1991-06-19
FI906141A (fi) 1991-06-16
EP0432740A3 (en) 1992-01-02
AU6802490A (en) 1991-06-20
HU908258D0 (en) 1991-06-28
IL96659A0 (en) 1991-09-16
AU630261B2 (en) 1992-10-22
EP0432740B1 (de) 1995-03-08
JPH0517459A (ja) 1993-01-26
ATE119527T1 (de) 1995-03-15
KR910011813A (ko) 1991-08-07
CA2032282A1 (en) 1991-06-16
NZ236453A (en) 1992-07-28
NO905411L (no) 1991-06-17
HU209584B (en) 1994-08-29
ZA9010067B (en) 1991-09-25
HUT58306A (en) 1992-02-28
RU2017739C1 (ru) 1994-08-15
RU2021264C1 (ru) 1994-10-15
US5137897A (en) 1992-08-11
FI906141A0 (fi) 1990-12-13

Similar Documents

Publication Publication Date Title
NO172180C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,5,6-tetrahydropyridin-3-carboxaldehydoximderivater
NO905411D0 (no) Nye 2-substituerte 4-(3-alkyl-5-tert.-4-hydroksyfenyl)-tiazoler, fremgangsmaate for deres fremstilling samt anvendelse av forbindelsene.
NO159795C (no) Fremgangsmaate for fremstilling av 2-penemforbindelser.
AR035069A1 (es) Compuestos inhibidores de espiropirimidin-2,4,6-triona metaloproteinasas, composicion farmaceutica, procedimiento de tratamiento
OA07257A (fr) Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoïque, sels et dérivés, préparation et médicaments les contenant.
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
NO924949D0 (no) Piperidylsubstituerte indoler
SE8503466D0 (sv) Aminofenolforeningar
DK0573318T3 (da) 4-phenylcarbamoyl-3-isoxazolcarboxylsyreforbindelser, fremgangsmåde til deres fremstilling, farmaceutiske præparater med in
MX9205365A (es) Imidazolilmetil-piridinas y composicion farmaceutica que las contiene.
ES414954A1 (es) Procedimiento para la preparacion de 4-(4-bifenilil)-buta- noles.
FR2539415B1 (fr) Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique
SE8302452D0 (sv) Method for treatment of senile dementia
SE7706693L (sv) Sett att framstella hydrazinopyridazinderivat
FR2448544A1 (fr) Derives de thiazole et leur application en therapeutique
NO952194L (no) Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer
SE8901570D0 (sv) Organic salts of cysteine derivatives
ATE150311T1 (de) Verwendung von isokarbacyclinen zur vorbeugung oder behandlung von organkrankheiten
SE8306884D0 (sv) Akrylsyraderivat innehallande en syrehaltig heterocykel till anvendning som lekemedel, nya industriprodukter och framstellningsforfarande